Becton Dickinson’s (NYSE:BDX) decision to spin off its respiratory devices into a joint venture with Apax Partners will allow it to offload an underperforming segment and concentrate on its core business of diagnostics. And the agreement also highlights the growing involvement of private equity in the medtech industry.
{iframe}http://seekingalpha.com/article/3957885-bd-spin-points-private-equity-medtech{/iframe}